Once-weekly insulin icodec non-inferior to daily insulin degludec in patients with type 1 diabetes
1. Mean HbA1c reduction at 26 weeks was comparable in the weekly icodec and daily degludec groups....
Read MoreNov 30, 2023
1. Mean HbA1c reduction at 26 weeks was comparable in the weekly icodec and daily degludec groups....
Read MoreNov 29, 2023
1. The augmentation of usual intraoperative care with support from the Anesthesiology Control...
Read MoreNov 29, 2023
1. Colchicine did not significantly reduce the risk of atrial fibrillation or myocardial injury...
Read MoreNov 28, 2023
1. In this cross-sectional study, the odds of adequate or optimal adherence to direct-acting oral...
Read MoreNov 28, 2023
1. The median overall survival was 12.1 months in the erdafitinib group and 7.8 months in the...
Read MoreNov 28, 2023
1. Overall pathologic complete response to treatment of triple-negative breast cancer with a...
Read MoreNov 28, 2023
1. Patients who underwent the Ross procedure had a comparable survival rate to a matched general...
Read MoreNov 25, 2023
1. In this cross-sectional study, a higher internet gaming disorder (IGD) score was associated...
Read MoreNov 25, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 25, 2023
1. In this observational study, patients in high remote patient monitoring (RPM) practices had...
Read MoreNov 25, 2023
1. In this randomized controlled trial, the combination of vancomycin with cefazolin was not...
Read MoreNov 25, 2023
1. In this randomized noninferiority trial, pulsed-field ablation was noninferior to thermal...
Read MoreNov 25, 2023
1. This randomised control trial demonstrated that a standardised and manualised intervention in...
Read MoreNov 24, 2023
1. This randomized pilot study demonstrates that fasting blood glucose (FBG), systolic blood...
Read MoreNov 24, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 24, 2023
1. In these two randomized parallel-group trials, the use of gantenerumab did not lead to slower...
Read MoreNov 24, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 24, 2023
1. In this randomized controlled trial, universal decolonization with topical antiseptics...
Read MoreNov 24, 2023
1. In this randomized controlled trial of patients with patellofemoral pain (PFP), home-based...
Read MoreNov 23, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read More